U.S. Equities1h ago
Ginkgo Bioworks (DNA) at $7.06: Why Earnings Collapse Doesn't Tell the Full Story
DNA shares rose 1 percent as Wall Street braces for a 47 percent revenue miss this quarter—but improving unit economics and autonomous lab milestones suggest the market is pricing in worse